Founded as a spin-out from AstraZeneca in 2017, OnDosis is a Swedish start-up addressing one of the major opportunities in healthcare; personalized dosage of medicines. The proprietary technology platform is centered around a connected handheld dosing device that delivers tailored doses of oral medicines. By combining individual dosing of traditional drug-based medicines augmented by digital therapeutics, OnDosis opens a new chapter in personalized medicine where the mission is to improve patients’ life through delivering the perfect dosage; individualized, intuitive, and intelligent.
![FM2-exploded_orange-2[13]](https://mnd-assets.mynewsdesk.com/image/upload/ar_16:9,c_fill,dpr_auto,f_auto,g_sm,q_auto:good,w_746/zsbhmjjmnfzc6uga5nmh)
